Showing results (291-300 of 382) with videos related to
Sort By:
Pageof 39
Blood|January 12, 2012
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterationsMichael W M Kühn, Ina Radtke, Lars Bullinger, et al.Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.Leukemia|March 2, 2018
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisChristopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.Blood|October 2, 2014
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantationRichard F Schlenk, Sabine Kayser, Lars Bullinger, et al.European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer PatientsPia Weinländer, Sara Hadzibegovic, Jan Porthun, et al.Haematologica|December 9, 2017
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemiaEdith Schneider, Anna Staffas, Linda Röhner, et al.Pageof 39